Aberrant signaling pathways in meningiomas

Brian T. Ragel, Randy L. Jensen

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.

Original languageEnglish (US)
Pages (from-to)315-324
Number of pages10
JournalJournal of Neuro-Oncology
Volume99
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Meningioma
Growth and Development
Carcinogenesis
RNA
Apoptosis
Technology
Growth

Keywords

  • Cell signal pathways
  • Meningioma
  • Merlin
  • Protein 4.1B

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Aberrant signaling pathways in meningiomas. / Ragel, Brian T.; Jensen, Randy L.

In: Journal of Neuro-Oncology, Vol. 99, No. 3, 09.2010, p. 315-324.

Research output: Contribution to journalArticle

Ragel, Brian T. ; Jensen, Randy L. / Aberrant signaling pathways in meningiomas. In: Journal of Neuro-Oncology. 2010 ; Vol. 99, No. 3. pp. 315-324.
@article{3abd05fbd6714ea298edf9313c1cfbd6,
title = "Aberrant signaling pathways in meningiomas",
abstract = "In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.",
keywords = "Cell signal pathways, Meningioma, Merlin, Protein 4.1B",
author = "Ragel, {Brian T.} and Jensen, {Randy L.}",
year = "2010",
month = "9",
doi = "10.1007/s11060-010-0381-8",
language = "English (US)",
volume = "99",
pages = "315--324",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Aberrant signaling pathways in meningiomas

AU - Ragel, Brian T.

AU - Jensen, Randy L.

PY - 2010/9

Y1 - 2010/9

N2 - In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.

AB - In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.

KW - Cell signal pathways

KW - Meningioma

KW - Merlin

KW - Protein 4.1B

UR - http://www.scopus.com/inward/record.url?scp=77957561248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957561248&partnerID=8YFLogxK

U2 - 10.1007/s11060-010-0381-8

DO - 10.1007/s11060-010-0381-8

M3 - Article

C2 - 20838852

AN - SCOPUS:77957561248

VL - 99

SP - 315

EP - 324

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -